BAGNOLINI, GRETA
 Distribuzione geografica
Continente #
EU - Europa 309
NA - Nord America 230
AS - Asia 98
AF - Africa 16
SA - Sud America 7
OC - Oceania 2
Totale 662
Nazione #
US - Stati Uniti d'America 230
IT - Italia 161
IN - India 28
GB - Regno Unito 26
SG - Singapore 25
IE - Irlanda 23
DE - Germania 18
SE - Svezia 18
CN - Cina 17
FR - Francia 13
CH - Svizzera 12
NL - Olanda 9
TG - Togo 9
TW - Taiwan 9
BR - Brasile 7
HK - Hong Kong 7
BG - Bulgaria 5
JP - Giappone 5
CZ - Repubblica Ceca 4
JO - Giordania 4
EG - Egitto 3
ES - Italia 3
KR - Corea 3
PL - Polonia 3
RU - Federazione Russa 3
AT - Austria 2
AU - Australia 2
BE - Belgio 2
FI - Finlandia 2
NG - Nigeria 2
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
MU - Mauritius 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 662
Città #
Bologna 62
Fairfield 36
Chandler 29
Dublin 23
Singapore 23
Ashburn 21
Seattle 21
Houston 17
Southend 16
Redmond 14
Woodbridge 14
Cambridge 11
Genoa 9
Lomé 9
Wilmington 8
Amsterdam 7
Milan 6
Porto Alegre 6
Princeton 6
Hyderabad 5
Sofia 5
Taipei 5
Amman 4
Carpi 4
Hong Kong 4
Lucca 4
New York 4
Näfels 4
Olomouc 4
Rome 4
Shanghai 4
Zurich 4
Berlin 3
Bern 3
Bremen 3
Cairo 3
Eraclea 3
Modena 3
Russi 3
Tokyo 3
Wanchai 3
Abeokuta 2
Ancona 2
Beijing 2
Bengaluru 2
Camden 2
Chicago 2
Colombes 2
Croton-on-Hudson 2
Des Moines 2
Frankfurt am Main 2
Giussano 2
Gothenburg 2
Grenoble 2
Groningen 2
Hamyang-gun 2
Helsinki 2
Imola 2
Kaohsiung City 2
Lambeth 2
Milwaukee 2
Nanjing 2
Naples 2
Nerviano 2
New Delhi 2
New Taipei City 2
Redwood City 2
Rimini 2
San Diego 2
San Giuliano Milanese 2
Sirone 2
Slough 2
Stockholm 2
Trieste 2
Turin 2
Vienna 2
Archway 1
Arroyo de la Encomienda 1
Asansol 1
Barcelona 1
Breda di Piave 1
Bühl 1
Caserta 1
Cento 1
Corato 1
Cosenza 1
Dearborn 1
Diano Arentino 1
Florence 1
Forlì 1
Genova 1
Gornsdorf 1
Gurgaon 1
Hangzhou 1
Hayamiya 1
Kiev 1
Kolkata 1
La Jolla 1
Lausanne 1
Les Matelles 1
Totale 514
Nome #
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 170
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 170
Inhibition of Urease, a Ni-Enzyme: The Reactivity of a Key Thiol With Mono- and Di-Substituted Catechols Elucidated by Kinetic, Structural, and Theoretical Studies 114
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 80
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer 67
Identification of RAD51-BRCA2 Inhibitors Using N-Acylhydrazone-Based Dynamic Combinatorial Chemistry 44
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 30
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives 11
Totale 686
Categoria #
all - tutte 1.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 2 0 3 4 6 5 7 7 3 4 0
2020/2021113 4 1 0 4 24 37 6 0 23 4 5 5
2021/202291 10 4 4 3 5 5 7 14 8 5 12 14
2022/2023142 8 19 7 17 10 9 7 10 21 10 8 16
2023/2024236 11 9 4 7 18 19 21 7 10 18 70 42
2024/202547 47 0 0 0 0 0 0 0 0 0 0 0
Totale 686